The Department of Health has been notified of the ongoing critical shortage of benzathine benzylpenicillin (Bicillin L-A) products. As such, there is a need to consider implementing measures to conserve benzathine benzylpenicillin products where possible.
Bicillin L-A 1.2 million unit prefilled syringes for injection will be in shortage until December 2025. Additionally, the shortage of Bicillin L-A (benzathine benzylpenicillin tetrahydrate) 600,000 unit prefilled syringes for injection will continue until the end of October 2025.
Refer to TGA website for updates regarding further changes to supply and the TGA 19A approvals database for updates on further S19A alternatives.
Resources